Pharvaris (PHVS) EPS (Diluted) (2020 - 2026)

Pharvaris (PHVS) EPS (Diluted) (2020 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EPS (Diluted) (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - 0.00
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn 0.15
4 NuCana 279.75 Bn 279.75 Bn - -368,323.02
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn 4.02
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn 6.75
7 Belite Bio 62.51 Bn 62.51 Bn - 0.00
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn 7.33
9 Revolution Medicines 37.78 Bn 37.78 Bn - -2.29
10 Pharvaris 2.17 Bn 1.88 Bn - -0.77

Historic Data

Download Data
DateValue
Mar 31, 2026 -0.77
Dec 31, 2025 -0.91
Sep 30, 2025 -0.80
Jun 30, 2025 0.96
Mar 31, 2025 -0.90
Dec 31, 2024 -0.69
Sep 30, 2024 -2,117.96
Jun 30, 2024 1,475.75
Mar 31, 2024 -0.79
Dec 31, 2023 -0.92
Sep 30, 2023 -3,191.56
Jun 30, 2023 2,961.91
Mar 31, 2023 -0.72
Dec 31, 2022 -1.19
Sep 30, 2022 -517.85
Jun 30, 2022 841.34
Mar 31, 2022 -0.59
Dec 31, 2021 1.14 Mn
Sep 30, 2021 -2.22
Jun 30, 2021 -3.77